GenSight Biologics SA(DE:G49N)
€0.07-0.00 (-1.47%)
DE:G49N
GenSight Biologics SA financials statements
€0.07
At close:-0.00 (-1.47%)
GenSight Biologics SA (G49N) Income Statement
1 Followers
GenSight Biologics SA Income Statement
Last quarter (Q2 2026), GenSight Biologics SA's total revenue was €-856.00K, a decrease of 149.54% from the same quarter last year. In Q2, GenSight Biologics SA's net income was €-10.27M. See GenSight Biologics SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 1.00K | € 2.63M | € 1.27M | € 2.58M | € 5.28M | |
| € 1.00K | € 2.63M | € 3.00M | € 2.58M | € 5.28M | |
| € 11.06M | € 18.44M | € 32.66M | € 30.42M | € 33.40M | |
| Depreciation and Amortization | € 465.00K | € 1.06M | € 3.03M | € 1.06M | € 928.00K |
| € -11.24M | € -14.76M | € -21.73M | € -26.77M | € -25.52M | |
| € -11.71M | € -15.81M | € -29.70M | € -27.84M | € -28.13M | |
| € -336.00K | € 1.83M | € 3.48M | € 215.00K | € -489.00K | |
| € -12.04M | € -13.98M | € -26.22M | € -27.62M | € -28.61M | |
| € -12.04M | € -14.00M | € -26.22M | € -27.62M | € -28.62M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.08 | € -0.15 | € -0.54 | € -0.60 | € -0.63 |
| Diluted EPS | € -0.08 | € -0.15 | € -0.54 | € -0.60 | € -0.63 |
| Weighted Average Shares Outstanding | 148.30M | 95.76M | 48.32M | 46.33M | 45.15M |
| Weighted Average Shares Outstanding (Diluted) | 148.30M | 95.76M | 48.32M | 46.33M | 45.15M |
Currency in EUR
